These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 26407256

  • 1. Procalcitonin (PCT) and Kawasaki Disease: Does PCT Correlate With IVIG-Resistant Disease, Admission to the Intensive Care Unit, or Development of Coronary Artery Lesions?
    Dominguez SR, Martin B, Heizer H, Jone PN, Tong S, Davidson J, Anderson MS, Glodé MP.
    J Pediatric Infect Dis Soc; 2016 Sep; 5(3):297-302. PubMed ID: 26407256
    [Abstract] [Full Text] [Related]

  • 2. Clinical implications of procalcitonin in Kawasaki disease: a useful candidate for differentiating from sepsis and evaluating IVIG responsiveness.
    Niu MM, Jiang Q, Ruan JW, Liu HH, Chen WX, Qiu Z, Fan GZ, Li RX, Wei W, Hu P.
    Clin Exp Med; 2021 Nov; 21(4):633-643. PubMed ID: 33839960
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.
    Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.
    Arthritis Rheum; 2013 Mar; 65(3):805-14. PubMed ID: 23440694
    [Abstract] [Full Text] [Related]

  • 4. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 5. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
    Jing F, Weng H, Pei Q, Zhang J, Liu R, Yi Q.
    Clin Exp Med; 2022 Nov 21; 22(4):621-628. PubMed ID: 35039938
    [Abstract] [Full Text] [Related]

  • 6. Predictive value of monocyte to HDL-C ratio for coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease.
    Wang JR, Zhao HZ, Chang LJ, Xu X, Gao Y, Li M, Kong QY, Wang MM, Zhao CF.
    Eur J Pediatr; 2023 Oct 21; 182(10):4399-4406. PubMed ID: 37480545
    [Abstract] [Full Text] [Related]

  • 7. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 21; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 8. Predictive value of serum procalcitonin for both initial and repeated immunoglobulin resistance in Kawasaki disease: a prospective cohort study.
    Shao S, Luo C, Zhou K, Hua Y, Wu M, Liu L, Liu X, Wang C.
    Pediatr Rheumatol Online J; 2019 Nov 27; 17(1):78. PubMed ID: 31775782
    [Abstract] [Full Text] [Related]

  • 9. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Nov 27; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 10. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H, Cai J, Zhang R, Shuai S, Tang M, Ju R, Hu Y, Zuo T, Yang Y.
    J Int Med Res; 2024 May 27; 52(5):3000605241252115. PubMed ID: 38713460
    [Abstract] [Full Text] [Related]

  • 11. TNF-α is superior to conventional inflammatory mediators in forecasting IVIG nonresponse and coronary arteritis in Chinese children with Kawasaki disease.
    Hu P, Jiang GM, Wu Y, Huang BY, Liu SY, Zhang DD, Xu Y, Wu YF, Xia X, Wei W, Hu B.
    Clin Chim Acta; 2017 Aug 27; 471():76-80. PubMed ID: 28526535
    [Abstract] [Full Text] [Related]

  • 12. Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease.
    Lu Y, Chen T, Wen Y, Si F, Wu X, Yang Y.
    BMC Pediatr; 2021 Sep 16; 21(1):406. PubMed ID: 34530763
    [Abstract] [Full Text] [Related]

  • 13. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease.
    Duan Y, Li H, Luo D, Jiang J, Liu B, Li G.
    Int Immunopharmacol; 2023 Sep 16; 122():110600. PubMed ID: 37423157
    [Abstract] [Full Text] [Related]

  • 14. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glodé MP, Dominguez SR.
    Pediatr Infect Dis J; 2018 Oct 16; 37(10):976-980. PubMed ID: 29461447
    [Abstract] [Full Text] [Related]

  • 15. Procalcitonin as a Biomarker of Unresponsiveness to Intravenous Immunoglobulin for Kawasaki Disease.
    Nakamura N, Muto T, Masuda Y, Numoto S, Kodama S, Miyamoto R, Miyata K, Hayakawa T, Mori H, Kuroyanagi Y, Akaihata M, Iwayama H, Kurahashi H, Shimomura Y, Nagai T, Hori T, Agata H, Okumura A.
    Pediatr Infect Dis J; 2020 Sep 16; 39(9):857-861. PubMed ID: 32433223
    [Abstract] [Full Text] [Related]

  • 16. [Risk factors for coronary artery lesions secondary to Kawasaki disease in children].
    Deng YC, Wang X, Tang XC, Huang CZ, Yang J, Mo LY.
    Zhongguo Dang Dai Er Ke Za Zhi; 2015 Sep 16; 17(9):927-31. PubMed ID: 26412172
    [Abstract] [Full Text] [Related]

  • 17. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 16; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 18. Facial nerve palsy may indicate coronary artery lesions in Kawasaki disease.
    Chen J, Liu P, Hu W, Xu Y, Deng J.
    Clin Rheumatol; 2021 Oct 16; 40(10):4191-4197. PubMed ID: 34059986
    [Abstract] [Full Text] [Related]

  • 19. Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease.
    Türkuçar S, Yıldız K, Acarı C, Dundar HA, Kır M, Ünsal E.
    Turk J Pediatr; 2020 Oct 16; 62(1):1-9. PubMed ID: 32253860
    [Abstract] [Full Text] [Related]

  • 20. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W, He X, Zhang L, Wang Z, Wang Y, Lin H, Yuan J, Xie X, Qin Y, Huang P.
    Cardiovasc Ther; 2021 Oct 16; 2021():6660407. PubMed ID: 34239607
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.